Michael A. Kelly
Michael A. Kelly

Michael A. Kelly

Director

Michael A. Kelly has served as a member of the Board since December 2020. Mr. Kelly is a former senior executive of Amgen, Inc. and is currently acting as Founder & President of Sentry Hill Partners, LLC, a global life sciences transformation and management consulting business founded by Mr. Kelly in 2018. Mr. Kelly has more than two decades of executive experience as a senior leader in the life sciences industry serving in various strategic finance and operations positions at Amgen Inc., most recently as Senior Vice President, Global Business Services and Vice President & CFO, International Commercial Operations. Mr. Kelly has also held positions at Biogen, Tanox, and Monsanto Life Sciences. Mr. Kelly is an independent member of the Board of Directors for publicly traded DMC Global, Inc., NeoGenomics, Inc., and Prime Medicine, Inc. Previously, he served on the Board of Hookipa Pharma, Inc. He also serves on the Council of Advisors and was the former audit committee chairman for Direct Relief, a humanitarian aid organization focused on health outcomes and disaster relief. Mr. Kelly holds a BSc in business administration from Florida A&M University, concentrating in Finance and Industrial Relations.

Mr. Kelly serves as member of the Audit and Compliance Committee and as member of the Science and Technology Committee.

Back to Board of Directors